Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
RNA-Binding Protein EWS | 10 | 2024 | 216 | 2.150 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 5 | 2023 | 105 | 1.920 |
Why?
|
Oncogene Proteins, Fusion | 13 | 2024 | 1581 | 1.500 |
Why?
|
Wilms Tumor | 7 | 2024 | 373 | 1.230 |
Why?
|
Chromatin | 12 | 2023 | 2934 | 1.190 |
Why?
|
In Situ Hybridization | 12 | 2021 | 1950 | 0.920 |
Why?
|
Bone Neoplasms | 6 | 2021 | 2529 | 0.770 |
Why?
|
Gene Expression Regulation, Neoplastic | 19 | 2023 | 8428 | 0.760 |
Why?
|
Tumor Suppressor Proteins | 10 | 2016 | 2849 | 0.750 |
Why?
|
Microsatellite Repeats | 2 | 2018 | 802 | 0.670 |
Why?
|
Odontogenic Tumors | 3 | 2024 | 45 | 0.600 |
Why?
|
Otx Transcription Factors | 1 | 2017 | 43 | 0.590 |
Why?
|
Calmodulin-Binding Proteins | 2 | 2019 | 249 | 0.590 |
Why?
|
Gene Silencing | 2 | 2018 | 1538 | 0.580 |
Why?
|
Enhancer Elements, Genetic | 3 | 2018 | 1341 | 0.570 |
Why?
|
Genes, Wilms Tumor | 2 | 2007 | 94 | 0.560 |
Why?
|
Chromatin Assembly and Disassembly | 4 | 2020 | 635 | 0.560 |
Why?
|
Medulloblastoma | 2 | 2019 | 683 | 0.510 |
Why?
|
Adenocarcinoma, Clear Cell | 3 | 2021 | 221 | 0.510 |
Why?
|
Salivary Gland Neoplasms | 3 | 2024 | 298 | 0.500 |
Why?
|
WT1 Proteins | 3 | 2010 | 178 | 0.490 |
Why?
|
RNA-Binding Proteins | 3 | 2020 | 1903 | 0.480 |
Why?
|
Hepatoblastoma | 1 | 2013 | 87 | 0.450 |
Why?
|
Sirtuins | 3 | 2022 | 323 | 0.440 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2013 | 102 | 0.430 |
Why?
|
Sarcoma, Clear Cell | 2 | 2024 | 76 | 0.430 |
Why?
|
DNA | 5 | 2023 | 7301 | 0.430 |
Why?
|
Cerebellar Neoplasms | 1 | 2017 | 587 | 0.410 |
Why?
|
Adaptor Proteins, Signal Transducing | 9 | 2015 | 2916 | 0.400 |
Why?
|
Transcription, Genetic | 6 | 2022 | 7722 | 0.380 |
Why?
|
Cell Line, Tumor | 24 | 2024 | 16689 | 0.370 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2024 | 443 | 0.360 |
Why?
|
Sarcoma, Synovial | 2 | 2021 | 167 | 0.340 |
Why?
|
Chromosomes, Human, X | 2 | 2007 | 296 | 0.330 |
Why?
|
Myocardial Ischemia | 2 | 2015 | 2148 | 0.300 |
Why?
|
Kidney Neoplasms | 5 | 2024 | 4262 | 0.300 |
Why?
|
Mesenchymal Stem Cells | 4 | 2018 | 1632 | 0.260 |
Why?
|
Wnt Proteins | 3 | 2016 | 721 | 0.260 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2023 | 388 | 0.250 |
Why?
|
Transcription Factors | 9 | 2022 | 12208 | 0.240 |
Why?
|
Antigens, Nuclear | 2 | 2015 | 192 | 0.240 |
Why?
|
Gene Expression Profiling | 5 | 2020 | 9438 | 0.240 |
Why?
|
Liver Neoplasms | 3 | 2015 | 4253 | 0.240 |
Why?
|
SOXB1 Transcription Factors | 2 | 2016 | 284 | 0.240 |
Why?
|
Neoplastic Stem Cells | 4 | 2017 | 1376 | 0.230 |
Why?
|
Sequence Analysis, RNA | 6 | 2017 | 2012 | 0.230 |
Why?
|
Cardiomyopathies | 1 | 2015 | 1912 | 0.220 |
Why?
|
Multiprotein Complexes | 4 | 2020 | 1119 | 0.220 |
Why?
|
Gene Deletion | 5 | 2018 | 2751 | 0.220 |
Why?
|
Hydrazines | 1 | 2024 | 226 | 0.210 |
Why?
|
Single-Cell Analysis | 5 | 2021 | 2183 | 0.210 |
Why?
|
Soft Tissue Neoplasms | 2 | 2022 | 1363 | 0.210 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2022 | 88 | 0.200 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2022 | 248 | 0.200 |
Why?
|
Pharmacy | 1 | 2023 | 91 | 0.200 |
Why?
|
Salivary Glands | 2 | 2021 | 229 | 0.200 |
Why?
|
RNA, Untranslated | 2 | 2018 | 453 | 0.200 |
Why?
|
Adenocarcinoma | 5 | 2020 | 6364 | 0.200 |
Why?
|
Cell Transformation, Neoplastic | 6 | 2023 | 2942 | 0.190 |
Why?
|
Epigenesis, Genetic | 5 | 2020 | 3647 | 0.190 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2017 | 1114 | 0.190 |
Why?
|
Interferons | 2 | 2022 | 706 | 0.190 |
Why?
|
Kidney | 5 | 2010 | 7186 | 0.180 |
Why?
|
RNA, Viral | 2 | 2021 | 2902 | 0.180 |
Why?
|
Nuclear Proteins | 4 | 2022 | 5853 | 0.180 |
Why?
|
Aniline Compounds | 2 | 2015 | 986 | 0.170 |
Why?
|
DNA-Binding Proteins | 6 | 2022 | 9648 | 0.170 |
Why?
|
Jaw Neoplasms | 1 | 2019 | 70 | 0.170 |
Why?
|
Humans | 76 | 2024 | 744343 | 0.160 |
Why?
|
Cell Survival | 4 | 2017 | 5882 | 0.160 |
Why?
|
Retinoblastoma Protein | 1 | 2022 | 704 | 0.160 |
Why?
|
Retroperitoneal Space | 1 | 2019 | 176 | 0.160 |
Why?
|
Mandibular Neoplasms | 1 | 2019 | 129 | 0.160 |
Why?
|
Triazoles | 1 | 2024 | 911 | 0.160 |
Why?
|
Skull Neoplasms | 1 | 2019 | 173 | 0.160 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2019 | 116 | 0.160 |
Why?
|
Facial Bones | 1 | 2019 | 201 | 0.160 |
Why?
|
Melanoma, Experimental | 1 | 2021 | 561 | 0.150 |
Why?
|
DNA Contamination | 1 | 2017 | 19 | 0.150 |
Why?
|
Viral Vaccines | 1 | 2003 | 636 | 0.150 |
Why?
|
Pancreatic Neoplasms | 4 | 2019 | 5256 | 0.150 |
Why?
|
RANK Ligand | 1 | 2019 | 326 | 0.150 |
Why?
|
Lung Neoplasms | 6 | 2023 | 13102 | 0.150 |
Why?
|
Proto-Oncogene Proteins | 6 | 2018 | 4554 | 0.150 |
Why?
|
Papillomaviridae | 1 | 2003 | 1119 | 0.150 |
Why?
|
Dystrophin | 1 | 2018 | 285 | 0.150 |
Why?
|
Tumor Cells, Cultured | 4 | 2018 | 6314 | 0.140 |
Why?
|
Prolactin | 1 | 2019 | 669 | 0.140 |
Why?
|
Immunohistochemistry | 6 | 2021 | 11366 | 0.140 |
Why?
|
Stromal Cells | 2 | 2019 | 1355 | 0.140 |
Why?
|
Mice | 26 | 2022 | 81183 | 0.140 |
Why?
|
Barrett Esophagus | 1 | 2020 | 494 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 380 | 0.140 |
Why?
|
Gene Rearrangement | 2 | 2019 | 1179 | 0.140 |
Why?
|
Apoptosis | 7 | 2024 | 9727 | 0.140 |
Why?
|
Animals | 32 | 2022 | 168757 | 0.140 |
Why?
|
Protein Binding | 5 | 2020 | 9386 | 0.140 |
Why?
|
Liposarcoma | 1 | 2019 | 333 | 0.140 |
Why?
|
Tumor Microenvironment | 2 | 2019 | 3586 | 0.130 |
Why?
|
In Situ Hybridization, Fluorescence | 5 | 2021 | 2649 | 0.130 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2020 | 1222 | 0.130 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2015 | 87 | 0.130 |
Why?
|
Apoptosis Regulatory Proteins | 4 | 2015 | 1157 | 0.130 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2015 | 27 | 0.130 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2016 | 188 | 0.130 |
Why?
|
Repressor Proteins | 3 | 2016 | 3023 | 0.130 |
Why?
|
Principal Component Analysis | 2 | 2017 | 940 | 0.130 |
Why?
|
Gene Expression Regulation | 5 | 2016 | 12072 | 0.130 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2015 | 173 | 0.130 |
Why?
|
Azacitidine | 1 | 2017 | 347 | 0.130 |
Why?
|
Oligodendroglioma | 1 | 2016 | 279 | 0.130 |
Why?
|
Human papillomavirus 18 | 1 | 2015 | 128 | 0.130 |
Why?
|
Neoplasms | 6 | 2022 | 21683 | 0.130 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2017 | 798 | 0.120 |
Why?
|
Point Mutation | 3 | 2016 | 1623 | 0.120 |
Why?
|
Sulfonamides | 2 | 2015 | 1938 | 0.120 |
Why?
|
Isocitrate Dehydrogenase | 2 | 2017 | 871 | 0.120 |
Why?
|
Cancer Vaccines | 1 | 2022 | 1023 | 0.120 |
Why?
|
Mice, Inbred NOD | 2 | 2019 | 1878 | 0.120 |
Why?
|
Cell Lineage | 3 | 2019 | 2504 | 0.120 |
Why?
|
Morpholines | 2 | 2015 | 571 | 0.120 |
Why?
|
Human papillomavirus 16 | 1 | 2015 | 262 | 0.120 |
Why?
|
Cell Differentiation | 9 | 2023 | 11483 | 0.120 |
Why?
|
Sequence Analysis, DNA | 2 | 2023 | 4803 | 0.110 |
Why?
|
Mice, SCID | 2 | 2019 | 2716 | 0.110 |
Why?
|
beta Catenin | 2 | 2010 | 1059 | 0.110 |
Why?
|
Leukemia, Myeloid | 1 | 2016 | 707 | 0.110 |
Why?
|
Serine Endopeptidases | 1 | 2018 | 1072 | 0.110 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2013 | 182 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2022 | 2948 | 0.110 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2015 | 2214 | 0.110 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2013 | 271 | 0.100 |
Why?
|
Carcinoma | 1 | 2024 | 2375 | 0.100 |
Why?
|
Lung | 2 | 2021 | 9856 | 0.100 |
Why?
|
Albumins | 1 | 2014 | 569 | 0.100 |
Why?
|
RNA, Messenger | 7 | 2018 | 13033 | 0.100 |
Why?
|
Zebrafish Proteins | 1 | 2018 | 1005 | 0.100 |
Why?
|
Promoter Regions, Genetic | 4 | 2022 | 5867 | 0.100 |
Why?
|
Antigen Presentation | 3 | 2002 | 1284 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3597 | 0.100 |
Why?
|
Protein Isoforms | 3 | 2016 | 1730 | 0.100 |
Why?
|
Serum Albumin | 1 | 2015 | 676 | 0.100 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2003 | 2020 | 0.100 |
Why?
|
DNA, Satellite | 1 | 2011 | 69 | 0.100 |
Why?
|
p300-CBP Transcription Factors | 1 | 2012 | 147 | 0.100 |
Why?
|
Female | 34 | 2024 | 380194 | 0.100 |
Why?
|
Introns | 1 | 2013 | 991 | 0.100 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 602 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2020 | 1583 | 0.090 |
Why?
|
Autoantigens | 1 | 2015 | 892 | 0.090 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2085 | 0.090 |
Why?
|
Myocardium | 2 | 2015 | 4776 | 0.090 |
Why?
|
Protein Kinase Inhibitors | 3 | 2013 | 5535 | 0.090 |
Why?
|
Calcium-Binding Proteins | 1 | 2015 | 1081 | 0.090 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2019 | 1634 | 0.090 |
Why?
|
Receptors, Androgen | 1 | 2016 | 1058 | 0.090 |
Why?
|
Trans-Activators | 2 | 2022 | 2924 | 0.090 |
Why?
|
Sarcoma | 1 | 2021 | 1897 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 2023 | 318 | 0.090 |
Why?
|
Meningioma | 1 | 2018 | 1209 | 0.090 |
Why?
|
Bile Duct Neoplasms | 1 | 2014 | 567 | 0.090 |
Why?
|
Cholangiocarcinoma | 1 | 2014 | 516 | 0.090 |
Why?
|
Translocation, Genetic | 2 | 2022 | 1420 | 0.090 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2727 | 0.090 |
Why?
|
Genomics | 3 | 2019 | 5720 | 0.080 |
Why?
|
Male | 27 | 2021 | 350118 | 0.080 |
Why?
|
Meningeal Neoplasms | 1 | 2018 | 1241 | 0.080 |
Why?
|
Radiology | 1 | 2023 | 2100 | 0.080 |
Why?
|
Membrane Proteins | 5 | 2015 | 7880 | 0.080 |
Why?
|
Sequence Deletion | 1 | 2013 | 1526 | 0.080 |
Why?
|
Lymphoma, B-Cell | 1 | 2015 | 931 | 0.080 |
Why?
|
Lectins, C-Type | 2 | 2002 | 588 | 0.080 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2421 | 0.080 |
Why?
|
Oncogenes | 3 | 2022 | 1265 | 0.080 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6773 | 0.080 |
Why?
|
Mice, Nude | 5 | 2013 | 3689 | 0.080 |
Why?
|
RNA, Neoplasm | 1 | 2011 | 769 | 0.080 |
Why?
|
Binding Sites | 3 | 2023 | 6114 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2015 | 2109 | 0.080 |
Why?
|
Chromosome Deletion | 2 | 2016 | 1401 | 0.080 |
Why?
|
Metabolic Networks and Pathways | 1 | 2012 | 783 | 0.080 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2014 | 934 | 0.080 |
Why?
|
Forkhead Transcription Factors | 1 | 2015 | 1613 | 0.080 |
Why?
|
Ventricular Remodeling | 1 | 2015 | 1224 | 0.080 |
Why?
|
Cell Cycle Proteins | 4 | 2024 | 3462 | 0.070 |
Why?
|
Colonic Neoplasms | 2 | 2017 | 2541 | 0.070 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2007 | 245 | 0.070 |
Why?
|
Stomach Neoplasms | 1 | 2016 | 1333 | 0.070 |
Why?
|
DNA Methylation | 3 | 2017 | 4286 | 0.070 |
Why?
|
Transfection | 2 | 2019 | 5892 | 0.070 |
Why?
|
Base Sequence | 2 | 2016 | 12797 | 0.070 |
Why?
|
Prostatic Neoplasms | 3 | 2019 | 11124 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 2014 | 1741 | 0.070 |
Why?
|
HEK293 Cells | 4 | 2019 | 4204 | 0.070 |
Why?
|
Cells, Cultured | 3 | 2018 | 19229 | 0.070 |
Why?
|
Collagen | 1 | 2015 | 2689 | 0.070 |
Why?
|
Myocytes, Cardiac | 1 | 2015 | 1637 | 0.070 |
Why?
|
Dendritic Cells | 3 | 2002 | 2725 | 0.070 |
Why?
|
Signal Transduction | 5 | 2019 | 23403 | 0.070 |
Why?
|
Antineoplastic Agents | 3 | 2020 | 13695 | 0.070 |
Why?
|
Cell Line | 3 | 2013 | 15997 | 0.070 |
Why?
|
Glycoproteins | 2 | 2016 | 2263 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2013 | 1676 | 0.070 |
Why?
|
Biopsy | 4 | 2020 | 6756 | 0.070 |
Why?
|
Adenoma | 1 | 2016 | 2174 | 0.070 |
Why?
|
Cell Proliferation | 5 | 2020 | 10481 | 0.070 |
Why?
|
Breast Neoplasms | 3 | 2023 | 20822 | 0.070 |
Why?
|
Child | 10 | 2023 | 77709 | 0.060 |
Why?
|
RNA | 3 | 2022 | 2749 | 0.060 |
Why?
|
Intestinal Mucosa | 1 | 2016 | 3036 | 0.060 |
Why?
|
Child, Preschool | 5 | 2019 | 41006 | 0.060 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 2 | 2016 | 64 | 0.060 |
Why?
|
Nerve Tissue Proteins | 2 | 2015 | 4462 | 0.060 |
Why?
|
Adult | 13 | 2021 | 214055 | 0.060 |
Why?
|
Automation, Laboratory | 2 | 2015 | 101 | 0.060 |
Why?
|
Middle Aged | 15 | 2021 | 213383 | 0.060 |
Why?
|
Workflow | 2 | 2022 | 847 | 0.060 |
Why?
|
Protein Stability | 2 | 2020 | 557 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5221 | 0.060 |
Why?
|
Brain Neoplasms | 2 | 2017 | 8863 | 0.060 |
Why?
|
Fatty Acids | 1 | 2012 | 1809 | 0.060 |
Why?
|
RNA, Small Interfering | 4 | 2015 | 3505 | 0.060 |
Why?
|
Aged | 12 | 2021 | 163280 | 0.060 |
Why?
|
Glioblastoma | 3 | 2014 | 3481 | 0.060 |
Why?
|
Head and Neck Neoplasms | 2 | 2015 | 2734 | 0.060 |
Why?
|
Papillomavirus Infections | 1 | 2015 | 1587 | 0.060 |
Why?
|
Organoids | 2 | 2020 | 701 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2013 | 2455 | 0.060 |
Why?
|
Karyopherins | 1 | 2024 | 137 | 0.060 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2006 | 520 | 0.060 |
Why?
|
Stem Cells | 1 | 2016 | 3567 | 0.060 |
Why?
|
Databases, Bibliographic | 1 | 2003 | 128 | 0.060 |
Why?
|
Melanoma | 1 | 2021 | 5510 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4665 | 0.050 |
Why?
|
E2F1 Transcription Factor | 1 | 2022 | 190 | 0.050 |
Why?
|
Carrier Proteins | 3 | 2014 | 5021 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2021 | 15076 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2015 | 4034 | 0.050 |
Why?
|
Genes, BRCA1 | 1 | 2006 | 781 | 0.050 |
Why?
|
E2F Transcription Factors | 1 | 2022 | 277 | 0.050 |
Why?
|
Glioma | 1 | 2017 | 3401 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2006 | 578 | 0.050 |
Why?
|
Prognosis | 3 | 2019 | 29063 | 0.050 |
Why?
|
Epigenomics | 2 | 2020 | 903 | 0.050 |
Why?
|
Cell Nucleolus | 1 | 2022 | 166 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5686 | 0.050 |
Why?
|
Neoplasm Proteins | 2 | 2013 | 3703 | 0.050 |
Why?
|
Life Cycle Stages | 1 | 2022 | 160 | 0.050 |
Why?
|
Acetylation | 2 | 2016 | 1085 | 0.050 |
Why?
|
RNA, Ribosomal | 1 | 2022 | 246 | 0.050 |
Why?
|
Mutation | 6 | 2023 | 29786 | 0.050 |
Why?
|
Lamivudine | 1 | 2022 | 342 | 0.050 |
Why?
|
Transcription Factor AP-1 | 1 | 2022 | 317 | 0.050 |
Why?
|
Gene Expression | 4 | 2011 | 7799 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2023 | 5172 | 0.050 |
Why?
|
Mice, Transgenic | 3 | 2018 | 9734 | 0.050 |
Why?
|
Surface-Active Agents | 1 | 2020 | 159 | 0.050 |
Why?
|
Intestines | 2 | 2022 | 1924 | 0.050 |
Why?
|
Heterozygote | 1 | 2007 | 2804 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2015 | 705 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2010 | 13815 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2915 | 0.040 |
Why?
|
Medical Oncology | 2 | 2022 | 2265 | 0.040 |
Why?
|
Heart Failure | 2 | 2015 | 10900 | 0.040 |
Why?
|
DNA Copy Number Variations | 2 | 2019 | 1941 | 0.040 |
Why?
|
Phlebitis | 1 | 2019 | 31 | 0.040 |
Why?
|
Retinoid X Receptors | 1 | 2019 | 93 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2024 | 9239 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2024 | 871 | 0.040 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2020 | 311 | 0.040 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2019 | 70 | 0.040 |
Why?
|
Sex Chromatin | 1 | 2018 | 20 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 4751 | 0.040 |
Why?
|
Esophagoscopy | 1 | 2020 | 390 | 0.040 |
Why?
|
Calcium | 1 | 2012 | 5756 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 2 | 2016 | 1097 | 0.040 |
Why?
|
Molecular Sequence Data | 3 | 2010 | 18111 | 0.040 |
Why?
|
Alleles | 2 | 2007 | 6933 | 0.040 |
Why?
|
Estrogen Receptor alpha | 1 | 2023 | 577 | 0.040 |
Why?
|
Adenovirus E1A Proteins | 1 | 2018 | 76 | 0.040 |
Why?
|
Integrins | 1 | 2023 | 846 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2020 | 57776 | 0.040 |
Why?
|
Histones | 2 | 2020 | 2599 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2002 | 4479 | 0.040 |
Why?
|
Spheroids, Cellular | 1 | 2020 | 351 | 0.040 |
Why?
|
RNA Polymerase II | 1 | 2022 | 551 | 0.040 |
Why?
|
RNA Stability | 1 | 2020 | 321 | 0.040 |
Why?
|
Glycolysis | 1 | 2022 | 827 | 0.040 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2021 | 2043 | 0.040 |
Why?
|
Immunoblotting | 2 | 2012 | 1682 | 0.040 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2022 | 594 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3752 | 0.040 |
Why?
|
Mice, Inbred C57BL | 5 | 2010 | 21827 | 0.040 |
Why?
|
Doxorubicin | 1 | 2024 | 2234 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2021 | 538 | 0.040 |
Why?
|
Mucins | 1 | 2020 | 564 | 0.040 |
Why?
|
Phosphoproteins | 2 | 2021 | 2440 | 0.040 |
Why?
|
Mice, Knockout | 5 | 2016 | 14557 | 0.040 |
Why?
|
DNA, Neoplasm | 2 | 2014 | 1758 | 0.040 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2010 | 893 | 0.040 |
Why?
|
Liposomes | 1 | 2000 | 759 | 0.040 |
Why?
|
Th1 Cells | 1 | 2022 | 1057 | 0.040 |
Why?
|
Th2 Cells | 1 | 2022 | 1061 | 0.040 |
Why?
|
NIH 3T3 Cells | 2 | 2010 | 677 | 0.040 |
Why?
|
Autopsy | 1 | 2020 | 1020 | 0.040 |
Why?
|
Antigens | 1 | 2002 | 1466 | 0.040 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2019 | 320 | 0.040 |
Why?
|
Mucin-2 | 1 | 2016 | 49 | 0.040 |
Why?
|
RNA Probes | 1 | 2016 | 113 | 0.040 |
Why?
|
Inflammation | 1 | 2016 | 10638 | 0.040 |
Why?
|
Epithelial Cells | 2 | 2020 | 3690 | 0.040 |
Why?
|
Clone Cells | 1 | 2020 | 1692 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2018 | 712 | 0.030 |
Why?
|
Cyclooxygenase 2 | 1 | 2019 | 611 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2002 | 1366 | 0.030 |
Why?
|
Apolipoproteins A | 1 | 2016 | 94 | 0.030 |
Why?
|
Dinoprostone | 1 | 2019 | 600 | 0.030 |
Why?
|
Macrophages | 3 | 2020 | 5655 | 0.030 |
Why?
|
Receptors, Cell Surface | 2 | 2002 | 2866 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2016 | 147 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2021 | 728 | 0.030 |
Why?
|
Genome, Human | 2 | 2010 | 4420 | 0.030 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2021 | 789 | 0.030 |
Why?
|
U937 Cells | 1 | 2015 | 268 | 0.030 |
Why?
|
Plasma Cells | 1 | 2019 | 591 | 0.030 |
Why?
|
Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2015 | 17 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1142 | 0.030 |
Why?
|
Oncogene Protein v-akt | 1 | 2015 | 135 | 0.030 |
Why?
|
X Chromosome Inactivation | 1 | 2017 | 224 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2019 | 1341 | 0.030 |
Why?
|
Antigens, CD | 2 | 2002 | 4026 | 0.030 |
Why?
|
Osteonectin | 1 | 2014 | 34 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2019 | 873 | 0.030 |
Why?
|
RNA Interference | 2 | 2014 | 2889 | 0.030 |
Why?
|
Protein Transport | 1 | 2020 | 1988 | 0.030 |
Why?
|
Retinal Dehydrogenase | 1 | 2014 | 74 | 0.030 |
Why?
|
Arginase | 1 | 2015 | 79 | 0.030 |
Why?
|
Membrane Glycoproteins | 2 | 2002 | 3768 | 0.030 |
Why?
|
Immunity | 1 | 2020 | 1012 | 0.030 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2016 | 535 | 0.030 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2016 | 371 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 713 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11524 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2015 | 459 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2019 | 1285 | 0.030 |
Why?
|
Antigens, CD1 | 1 | 1997 | 437 | 0.030 |
Why?
|
Down-Regulation | 2 | 2013 | 3002 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3339 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2002 | 2258 | 0.030 |
Why?
|
Steroids | 1 | 2019 | 930 | 0.030 |
Why?
|
Glutamic Acid | 1 | 2019 | 1169 | 0.030 |
Why?
|
England | 1 | 2015 | 522 | 0.030 |
Why?
|
Co-Repressor Proteins | 1 | 2014 | 194 | 0.030 |
Why?
|
Telomerase | 1 | 2018 | 730 | 0.030 |
Why?
|
Young Adult | 4 | 2021 | 56430 | 0.030 |
Why?
|
Genes, ras | 1 | 2016 | 690 | 0.030 |
Why?
|
Immunoglobulin G | 2 | 2019 | 4560 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 553 | 0.030 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2014 | 186 | 0.030 |
Why?
|
Disease Progression | 2 | 2020 | 13284 | 0.030 |
Why?
|
Caspase 3 | 1 | 2015 | 758 | 0.030 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2016 | 651 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1584 | 0.030 |
Why?
|
5' Untranslated Regions | 1 | 2013 | 249 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2022 | 4386 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2016 | 1547 | 0.030 |
Why?
|
Kinetics | 1 | 2020 | 6473 | 0.030 |
Why?
|
Cerebellum | 1 | 2019 | 1488 | 0.030 |
Why?
|
bcl-X Protein | 1 | 2013 | 411 | 0.030 |
Why?
|
Fibrosis | 1 | 2019 | 2029 | 0.030 |
Why?
|
Viral Load | 1 | 2020 | 3299 | 0.030 |
Why?
|
Adolescent | 4 | 2021 | 85781 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12959 | 0.030 |
Why?
|
Phenotype | 4 | 2019 | 16365 | 0.030 |
Why?
|
RNA Splicing | 1 | 2016 | 907 | 0.020 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2011 | 92 | 0.020 |
Why?
|
Minor Histocompatibility Antigens | 2 | 2002 | 298 | 0.020 |
Why?
|
Neuroglia | 1 | 2016 | 927 | 0.020 |
Why?
|
Computational Biology | 1 | 2003 | 3521 | 0.020 |
Why?
|
DEAD-box RNA Helicases | 1 | 2013 | 375 | 0.020 |
Why?
|
PPAR alpha | 1 | 2012 | 197 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2016 | 2088 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2015 | 1094 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2023 | 77449 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2001 | 5524 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2013 | 1866 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 19905 | 0.020 |
Why?
|
Lentivirus | 1 | 2013 | 501 | 0.020 |
Why?
|
Proteomics | 1 | 2003 | 3638 | 0.020 |
Why?
|
Ovalbumin | 2 | 2002 | 719 | 0.020 |
Why?
|
Prostate | 1 | 2018 | 1774 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2019 | 18029 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 2987 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2015 | 2726 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4217 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2016 | 828 | 0.020 |
Why?
|
Lymph Node Excision | 1 | 2015 | 1261 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2016 | 851 | 0.020 |
Why?
|
Neurosecretory Systems | 1 | 2011 | 231 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 2386 | 0.020 |
Why?
|
Phylogeny | 1 | 2016 | 2803 | 0.020 |
Why?
|
Phosphorylation | 2 | 2013 | 8436 | 0.020 |
Why?
|
Genetic Engineering | 1 | 2015 | 951 | 0.020 |
Why?
|
DNA, Viral | 1 | 2015 | 2225 | 0.020 |
Why?
|
Genetic Variation | 1 | 2004 | 6544 | 0.020 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2011 | 338 | 0.020 |
Why?
|
Microglia | 1 | 2017 | 1266 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 1997 | 1838 | 0.020 |
Why?
|
Calcium Channels | 1 | 2012 | 622 | 0.020 |
Why?
|
Heterochromatin | 1 | 2011 | 296 | 0.020 |
Why?
|
Fibroblasts | 1 | 2019 | 4161 | 0.020 |
Why?
|
ras Proteins | 1 | 2013 | 1060 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2012 | 822 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2013 | 5974 | 0.020 |
Why?
|
Zinc Fingers | 1 | 2010 | 585 | 0.020 |
Why?
|
Luciferases | 1 | 2010 | 733 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 1997 | 2133 | 0.020 |
Why?
|
DNA Primers | 1 | 2012 | 2892 | 0.020 |
Why?
|
Reference Values | 1 | 2015 | 4982 | 0.020 |
Why?
|
Tight Junctions | 1 | 2010 | 311 | 0.020 |
Why?
|
Prostatectomy | 1 | 2016 | 1890 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2010 | 905 | 0.020 |
Why?
|
Infant | 2 | 2019 | 35136 | 0.020 |
Why?
|
Cytokines | 1 | 2022 | 7322 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5179 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2007 | 356 | 0.020 |
Why?
|
Cell Polarity | 1 | 2010 | 645 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3557 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2007 | 3920 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 1434 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4445 | 0.020 |
Why?
|
Embryo, Nonmammalian | 1 | 2010 | 895 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39050 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2886 | 0.020 |
Why?
|
Podocytes | 1 | 2010 | 396 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1692 | 0.020 |
Why?
|
Fetus | 1 | 2013 | 1880 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 53288 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2007 | 1375 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4149 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2015 | 21746 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6895 | 0.020 |
Why?
|
Astrocytes | 1 | 2013 | 1270 | 0.020 |
Why?
|
Karyotyping | 1 | 2007 | 1243 | 0.020 |
Why?
|
Proteins | 1 | 2000 | 6103 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 2008 | 0.020 |
Why?
|
Carcinoma in Situ | 1 | 2011 | 806 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2010 | 1117 | 0.020 |
Why?
|
Genes, Duplicate | 1 | 2004 | 33 | 0.020 |
Why?
|
Retroviridae | 1 | 2007 | 914 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2013 | 2969 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5319 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2015 | 8301 | 0.010 |
Why?
|
Receptors, Estradiol | 1 | 2003 | 19 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2001 | 10180 | 0.010 |
Why?
|
Rabbits | 1 | 2010 | 4894 | 0.010 |
Why?
|
Software Validation | 1 | 2003 | 59 | 0.010 |
Why?
|
MEDLINE | 1 | 2003 | 125 | 0.010 |
Why?
|
Embryonic Stem Cells | 1 | 2010 | 1294 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9313 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10943 | 0.010 |
Why?
|
Cohort Studies | 2 | 2018 | 40561 | 0.010 |
Why?
|
Cell Movement | 1 | 2014 | 5217 | 0.010 |
Why?
|
Heart Transplantation | 1 | 2015 | 3110 | 0.010 |
Why?
|
Gene Amplification | 1 | 2006 | 1063 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2011 | 2938 | 0.010 |
Why?
|
Gene Regulatory Networks | 1 | 2010 | 1708 | 0.010 |
Why?
|
Muramidase | 1 | 2001 | 174 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2011 | 2416 | 0.010 |
Why?
|
Tetanus Toxin | 1 | 2000 | 49 | 0.010 |
Why?
|
Drug Stability | 1 | 2000 | 291 | 0.010 |
Why?
|
Lymph Nodes | 2 | 2002 | 3474 | 0.010 |
Why?
|
United States | 2 | 2020 | 69872 | 0.010 |
Why?
|
Neurons | 1 | 2019 | 9338 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2012 | 3821 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 63114 | 0.010 |
Why?
|
Gene Dosage | 1 | 2004 | 1252 | 0.010 |
Why?
|
Drug Compounding | 1 | 2000 | 242 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 23338 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2010 | 3617 | 0.010 |
Why?
|
Rats | 1 | 2015 | 24260 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 2003 | 1092 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2007 | 4186 | 0.010 |
Why?
|
Zebrafish | 1 | 2010 | 2994 | 0.010 |
Why?
|
Endocytosis | 1 | 2002 | 985 | 0.010 |
Why?
|
Adoptive Transfer | 1 | 2000 | 844 | 0.010 |
Why?
|
Disease | 1 | 2003 | 680 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17446 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15540 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2003 | 2715 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2003 | 1783 | 0.010 |
Why?
|
Spleen | 1 | 2001 | 2362 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2011 | 4838 | 0.010 |
Why?
|
Lymphocytes | 1 | 2001 | 2617 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2000 | 2699 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2003 | 2716 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1997 | 805 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2000 | 1917 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1997 | 2327 | 0.010 |
Why?
|
Thymus Gland | 1 | 1997 | 1267 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 35421 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12261 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2000 | 2219 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 2003 | 3712 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2007 | 25625 | 0.000 |
Why?
|
Bipolar Disorder | 1 | 2003 | 5027 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 2002 | 9274 | 0.000 |
Why?
|
Hypertension | 1 | 2003 | 8480 | 0.000 |
Why?
|
Algorithms | 1 | 2003 | 13881 | 0.000 |
Why?
|
Models, Biological | 1 | 1997 | 9583 | 0.000 |
Why?
|